Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · IEX Real-Time Price · USD
1.450
-0.045 (-3.01%)
At close: Jul 2, 2024, 4:00 PM
1.430
-0.020 (-1.38%)
After-hours: Jul 2, 2024, 4:14 PM EDT
CPIX Revenue
Cumberland Pharmaceuticals had revenue of $38.83M in the twelve months ending March 31, 2024, down -3.08% year-over-year. Revenue in the quarter ending March 31, 2024 was $8.50M, a -7.88% decrease year-over-year. In the year 2023, Cumberland Pharmaceuticals had annual revenue of $39.55M, a decrease of -5.85%.
Revenue (ttm)
$38.83M
Revenue Growth
-3.08%
P/S Ratio
0.53
Revenue / Employee
$426,655
Employees
91
Market Cap
20.58M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 39.55M | -2.46M | -5.85% |
Dec 31, 2022 | 42.01M | 6.03M | 16.75% |
Dec 31, 2021 | 35.99M | -1.46M | -3.89% |
Dec 31, 2020 | 37.44M | 3.05M | 8.88% |
Dec 31, 2019 | 34.39M | 5.04M | 17.19% |
Dec 31, 2018 | 29.34M | -11.81M | -28.69% |
Dec 31, 2017 | 41.15M | 8.12M | 24.60% |
Dec 31, 2016 | 33.03M | -493.49K | -1.47% |
Dec 31, 2015 | 33.52M | -3.38M | -9.17% |
Dec 31, 2014 | 36.90M | 4.87M | 15.22% |
Dec 31, 2013 | 32.03M | -16.82M | -34.44% |
Dec 31, 2012 | 48.85M | -2.29M | -4.48% |
Dec 31, 2011 | 51.14M | 5.27M | 11.48% |
Dec 31, 2010 | 45.88M | 2.34M | 5.37% |
Dec 31, 2009 | 43.54M | 8.46M | 24.13% |
Dec 31, 2008 | 35.08M | 7.01M | 24.98% |
Dec 31, 2007 | 28.06M | 10.25M | 57.52% |
Dec 31, 2006 | 17.82M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Meihua International Medical Technologies Co. | 97.10M |
Nephros | 14.06M |
NeuroOne Medical Technologies | 3.73M |
Oncternal Therapeutics | 1.15M |
AIM ImmunoTech | 193.00K |
CPIX News
- 2 months ago - Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update - PRNewsWire
- 2 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 3 months ago - NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS - PRNewsWire
- 4 months ago - Cumberland Pharmaceuticals Reports Annual 2023 Financial Results - PRNewsWire
- 4 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS - PRNewsWire
- 8 months ago - Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results - PRNewsWire
- 8 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS - PRNewsWire
- 9 months ago - NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE - PRNewsWire